Comment on: International multicentre evaluation of a new anti‐idiotypic anti‐daratumumab for resolving pre‐transfusion interferences
Vox Sanguinis · 03.11.2026
DOI: 10.1111/vox.70411 ↗Kurz gefasst
Leserbrief in der Zeitschrift Vox Sanguinis, online erschienen am 03.11.2026. Verfasst von Yonka Lazarova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Transfusion Hematology, Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Sofia City, Bulgaria. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Laboratory of Transfusion Hematology, Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Sofia City, Bulgaria.
- Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Sofia City, Bulgaria.
- Department of Hematopoietic Stem Cell Transplantation, Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Sofia City, Bulgaria.
ORCID-Profile: Yonka Lazarova, Kameliya Milcheva, Krasen Venkov, Georgi Mihaylov, Andriyana Bankova
Zitieren
APA
Lazarova, Y., Milcheva, K., Venkov, K., Mihaylov, G., & Bankova, A. (2026). Comment on: International multicentre evaluation of a new anti‐idiotypic anti‐daratumumab for resolving pre‐transfusion interferences. Vox Sanguinis. https://doi.org/10.1111/vox.70411
Vancouver
Lazarova Y, Milcheva K, Venkov K, Mihaylov G, Bankova A. Comment on: International multicentre evaluation of a new anti‐idiotypic anti‐daratumumab for resolving pre‐transfusion interferences. Vox Sanguinis. 2026. doi:10.1111/vox.70411
BibTeX
@article{Lazarova2026,
author = {Lazarova, Yonka and Milcheva, Kameliya and Venkov, Krasen and Mihaylov, Georgi and Bankova, Andriyana},
title = {Comment on: International multicentre evaluation of a new anti‐idiotypic anti‐daratumumab for resolving pre‐transfusion interferences},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70411}
}
EUVIMED